
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions â written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Pheochromocytoma causes
Introduction
Overview
Overview
The most common cause of pheochromocytoma is sporadic mutations. Less common causes of pheochromocytoma include familial associations and association with syndromes. Familial pheochromocytoma may be caused by a mutation of either SDHD, VHL, SDHB, RET, NF1 genes.
Causes
Causes
Life-threatening Causes
- Pheochromocytoma due to any cause may be life-threatening which may result in death.
Common Causes
- In most cases of pheochromocytoma, the cause is unknown.
- Sporadic form is more common
Less Common Causes
Less common causes of pheochromocytoma include:
- Familial form
- Associated with syndromes- Neurofibromatosis 1, Von Hippel-Lindau disease, Multiple Endocrine Neoplasia 2A and 2B
Genetic Causes
Pheochromocytoma of the familial type may be caused by a mutation in the following genes:
- RET gene (MEN 2A, MEN 2B syndromes)
- NF1 gene
- VHL gene (VHL disease)
- SDHD, SDHB, and SDHC genes of the mitochondrial complex [1]
- SDHA, SDHAF2, TMEM127 (transmembrane protein 127), MAX (myc-associated factor X), FH (fumarate hydratase), PDH1, PDH2 (pyruvate dehydrogenase), HIF1alpha (hypoxia-inducible factor), MDH2 (malate dehydrogenase), and KIF1BĂ (kinesin family member) genes. [2]
Pheochromocytoma and paragangliomas (PPGL) susceptibility genes can be classified into the following clusters- [3] [4] [5]
- Cluster 1
- Mutations involving in overexpression of vascular endothelial growth factor (VEGF) as a result of pseudohypoxia
- Impaired DNA methylation leading to increased vascularization
- Cluster 2
- Activating mutations of Wnt-signaling pathway including Wnt receptor signaling and Hedgehog signaling.
- Mutations of CSDE1 (Cold shock domain containing E1) and MAML3 (Mastermind like transcriptional coactivator 3) genes7.
- Cluster 3
- Abnormal activation of kinase signaling pathways like PI3Kinase/AKT, RAS/RAF/ERK, and mTOR pathways.
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | No underlying causes |
| Ear Nose Throat | No underlying causes |
| Endocrine | No underlying causes |
| Environmental | No underlying causes |
| Gastroenterologic | No underlying causes |
| Genetic | No underlying causes |
| Hematologic | No underlying causes |
| Iatrogenic | No underlying causes |
| Infectious Disease | No underlying causes |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | No underlying causes |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | No underlying causes |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Miscellaneous | No underlying causes |
Causes in Alphabetical Order
List of causes of the disease in alphabetical order:
- Familial inheritance
- FH (fumarate hydratase) gene
- HIF1alpha (hypoxia-inducible factor) gene
- KIF1BĂ (kinesin family member) gene
- MAX (myc-associated factor X)
- MDH2 (malate dehydrogenase) gene
- NF1 gene– Neurofibromatosis 1 (NF1)
- PDH1, PDH2 (pyruvate dehydrogenase) gene
- RET gene- Multiple endocrine neoplasia (MEN 2A, MEN 2B)
- SDHA gene
- SDHB gene
- SDHC gene
- SDHD gene
- SDHAF2 gene
- Sporadic mutations
- TMEM127 gene
- Unknown origin
- VHL gene– Von-Hippel Lindau disease (VHL)
References
References
- â Gimm O (2005). “Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx”. Fam Cancer. 4 (1): 17â23. doi:10.1007/s10689-004-5740-1. PMIDÂ 15883706.
- â Jameson, J (2017). Harrison’s Principles of Internal Medicine 19th Edition and Harrison’s Manual of Medicine 19th Edition VAL PAK. New York: McGraw-Hill Medical. ISBNÂ 978-1260128857.
- â Jameson, J (2017). Harrison’s Principles of Internal Medicine 19th Edition and Harrison’s Manual of Medicine 19th Edition VAL PAK. New York: McGraw-Hill Medical. ISBNÂ 978-1260128857.
- â Eisenhofer G, Huynh TT, Pacak K, Brouwers FM, Walther MM, Linehan WM; et al. (2004). “Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome”. Endocr Relat Cancer. 11 (4): 897â911. doi:10.1677/erc.1.00838. PMIDÂ 15613462.
- â Lam AK (2017). “Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours”. Endocr Pathol. 28 (3): 213â227. doi:10.1007/s12022-017-9484-5. PMIDÂ 28477311.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2] Mohammed Abdelwahed M.D[3]
